HK1 and cancer: Finally, the compounds were examined in vitro for inhibitory activities against mitochondrial NADH: ubiquinone oxidoreductase (complex I) by targeting the AMPK/mTOR signaling pathway and inhibiting hexokinase, a key glycolytic enzyme, to prevent the Warburg effect in cancer cells.